29881-14-9

Basic information

• Product Name: 1,2-DIPHENYLCYCLOPROPANE
• Synonyms: 1,2-DIPHENYLCYCLOPROPANE;(2-Phenylcyclopropyl)benzene;Benzene, 1,1'-(1,2-cyclopropanediyl)bis-;cyclopropane,1,2-diphenyl-;1,2-Diphenylcyclopropane,cis+trans,97%;1,2-diphenylcyclopropane, cis + trans;1 2-DIPHENYLCYCLOPROPANE 95%
• CAS NO: 29881-14-9
• Molecular Formula: C₁₅H₁₄
• Molecular Weight: 194.27
• EINECS: 214-511-3
• Mol File: 29881-14-9.mol
• Article Data: 18

Chemical Properties

• Boiling Point: 175-177°C 14mm
• Flash Point: 175-177°C/14mm
• Appearance: /
• Density: 1,02 g/cm3
• Vapor Pressure: 0.00357mmHg at 25°C
• Refractive Index: 1.5960
• BRN: 2043299
• CAS DataBase Reference: 1,2-DIPHENYLCYCLOPROPANE(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2-DIPHENYLCYCLOPROPANE(29881-14-9)
• EPA Substance Registry System: 1,2-DIPHENYLCYCLOPROPANE(29881-14-9)

Safety Data

• Safety Statements: 24/25
• Hazardous Substances Data: 29881-14-9(Hazardous Substances Data)

Usage

General Description

1,2-Diphenylcyclopropane is a chemical compound with the formula C15H14. It is a cyclic organic compound composed of three carbon atoms and two benzene rings. 1,2-DIPHENYLCYCLOPROPANE is widely used in organic synthesis and it is known for its ability to undergo ring-opening reactions. Its unique structure and reactivity make it an important building block for creating other complex organic compounds. 1,2-Diphenylcyclopropane has also been studied for its potential applications in pharmaceuticals and materials science due to its interesting properties and potential for creating new molecules with unique properties.

InChI:InChI=1/C15H14/c1-3-7-12(8-4-1)14-11-15(14)13-9-5-2-6-10-13/h1-10,14-15H,11H2

Upstream product

• 201230-82-2 carbon monoxide 
• 24168-52-3 1,2-Diphenylcyclopropen 
• 591-50-4 iodobenzene 
• 100-42-5 styrene 
• 1666-17-7 benzaldehyde p-toluenesulfonylhydrazone 
• 94-41-7 benzalacetophenone 
• 59130-21-1 1,1-dichloro trans-2,3-diphenylcyclopropane 
• 645-49-8 cis-stilben 
• 123-72-8 butyraldehyde 
• 103-30-0 (E)-1,2-diphenyl-ethene 
• 14399-53-2 bis(iodomethyl)zinc 
• 75-11-6 diiodomethane 
• 908094-04-2 phenyldiazomethane 
• 16619-60-6 3,5-diphenyl-4,5-dihydro-1H-pyrazole 

Downstream Products

• 591-50-4 iodobenzene 
• 98124-49-3 1,3-bis(trichloroacetoxy)-1,3-diphenylpropane 
• 94848-66-5 1,2-di(4-iodophenyl)cyclopropane 
• 53215-16-0 3,5-diphenyl-4-nitro-1,2-oxazole 
• 2039-49-8 3,5-diphehylisoxazole 
• 100-52-7 benzaldehyde 
• 94-41-7 benzalacetophenone 
• 98-86-2 acetophenone 
• 90095-71-9 1,3-bis(trifluoracetoxy)-1,3-diphenylpropane 
• 40419-15-6 1-(n-Butylamino)-1,3-diphenylpropan 
• 14637-69-5 1-[4-(cis-2-phenylcyclopropyl)phenyl]ethanone 
• 14637-69-5 p-(trans-2-Phenylcyclopropyl)acetophenone 
• 4894-23-9 3,5-diphenyl-4,5-dihydro-isoxazole 
• 65662-66-0 (cis)-1,2-Bis(p-bromophenyl)cyclopropane 

Relevant articles and documents

(Salen)Mn(III)-catalyzed chemoselective acylazidation of olefins

We describe a (salen)Mn(iii)-catalyzed three-component reaction of aldehydes, olefins, and sodium azide for the installation of two useful groups (C═O and N3) into the double bond. Traditionally, (salen)Mn(iii) in conjunction with iodosobenzene is a classical catalysis system for epoxidation of olefins. Owing to the highly competitive oxygenation approaches, it is a true challenge to establish a distinct strategy for the exploration of new olefin transformations based on this (salen)Mn(iii) catalysis system. Herein, the key to this (salen)Mn(iii)-catalyzed acylazidation of olefins was the rational application of the distinct reactivity of oxomanganese(v) species which is capable of abstracting a hydrogen atom from a substrate C-H bond. This chemoselective reaction occurred in a precisely designed reaction sequence and tolerates complex molecular structures.

HEPATITIS C VIRUS INHIBITORS

This disclosure concerns novel compounds of Formula (I) as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds

ASYMMETRIC CYCLOPROPANATION

The present invention provides a method for asymmetric cyclopropanation of olefins comprising admixing an olefin, an enantiomerically enriched amino acid derivative, and a (halomethylene)zinc compound under conditions sufficient to produce an enantiomeric